February 12th, 2013 - EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
January 9th, 2013 - Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
November 14th, 2012 - EpiCept Reports Third Quarter 2012 Operating and Financial Results
November 8th, 2012 - Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Hellstrand K, Hermodsson S.
Histamine H2-receptor-mediated regulation of human natural killer cell activity.
Sawynok J, Esser MJ, Reid AR
Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82 (1999) 149-158.
November 14th, 2012 - EpiCept Corporation Third Quarter-2012 Earnings Call
August 8th, 2012 - EpiCept Corporation Second Quarter-2012 Earnings Call
February 29th, 2012 - EpiCept Corporation Fourth Quarter-Year End 2011 Earnings Call
February 13th, 2012 - BIO CEO & Investor Conference
January 10th, 2012 - 2012 OneMedForum